{
  "name": "Clinical Trials & Research",
  "framework": "clinical-trials",
  "version": "1.0",
  "description": "Keywords for clinical research including trial phases, study design, endpoints, and regulatory compliance for pharmaceutical and biotech research.",
  "source": "FDA Guidance, ICH Guidelines, ClinicalTrials.gov",
  "list_type": "grouped",
  "total_keywords": 82,
  "keywords": {
    "Trial Phases": [
      "phase 1",
      "phase i",
      "phase 2",
      "phase ii",
      "phase 3",
      "phase iii",
      "phase 4",
      "phase iv",
      "preclinical",
      "first in human",
      "dose escalation",
      "dose finding",
      "proof of concept",
      "pivotal trial",
      "confirmatory trial",
      "post-marketing",
      "pharmacovigilance",
      "safety study",
      "efficacy study"
    ],
    "Study Design": [
      "randomized controlled trial",
      "rct",
      "double-blind",
      "single-blind",
      "open-label",
      "placebo-controlled",
      "active-controlled",
      "crossover study",
      "parallel group",
      "adaptive design",
      "basket trial",
      "umbrella trial",
      "platform trial",
      "non-inferiority",
      "superiority",
      "equivalence",
      "intention to treat",
      "per protocol",
      "modified intention to treat"
    ],
    "Endpoints & Outcomes": [
      "primary endpoint",
      "secondary endpoint",
      "surrogate endpoint",
      "clinical endpoint",
      "composite endpoint",
      "overall survival",
      "progression-free survival",
      "disease-free survival",
      "objective response rate",
      "complete response",
      "partial response",
      "stable disease",
      "time to progression",
      "quality of life",
      "patient-reported outcome",
      "pro",
      "adverse event",
      "serious adverse event",
      "sae"
    ],
    "Regulatory & Compliance": [
      "informed consent",
      "institutional review board",
      "irb",
      "ethics committee",
      "good clinical practice",
      "gcp",
      "investigational new drug",
      "ind",
      "new drug application",
      "nda",
      "biologics license application",
      "bla",
      "clinical trial application",
      "cta",
      "data safety monitoring board",
      "dsmb",
      "protocol deviation",
      "protocol amendment",
      "site monitoring",
      "source data verification"
    ]
  }
}
